About Epygenix
Epygenix is a company based in Paramus (United States) founded in 2016. It operates as a B2B. Epygenix offers products and services including Pitolisant, ZYN002, EPX-100, and BP1.15205. Epygenix operates in a competitive market with competitors including Insitro, BridgeBio, ATAI, Forge Biologics and Spark Therapeutics, among others.
- Headquarter Paramus, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Harmony Biosciences Management, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Epygenix
Epygenix offers a comprehensive portfolio of products and services, including Pitolisant, ZYN002, EPX-100, and BP1.15205.
Drug for excessive daytime sleepiness in narcolepsy patients.
Gel for behavioral symptoms in Fragile X syndrome.
Modulates serotonin for Dravet and Lennox-Gastaut syndromes.
Orexin-2 receptor agonist for narcolepsy symptoms.
Funding Insights of Epygenix
Detailed funding history for Epygenix
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Epygenix
Investment portfolio details for Epygenix
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Epygenix
Detailed financials for Epygenix
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Epygenix Comparisons
Peer comparison for Epygenix
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Epygenix
Epygenix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insitro, BridgeBio, ATAI, Forge Biologics and Spark Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| Locked | Locked | Locked |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| Locked | Locked | Locked |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| Locked | Locked | Locked |
Gene therapies for rare diseases are developed to treat patients.
|
|
| Locked | Locked | Locked |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| Locked | Locked | Locked |
Provider of cell therapies to treat cancer and hematologic conditions
|
Detailed competitors of Epygenix
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Epygenix
Complete news archive for Epygenix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Epygenix
Epygenix was founded in 2016.
Epygenix is headquartered in Paramus, United States. It is registered at Paramus, New Jersey, United States.
Harmony Biosciences is a biotechnology company that focuses on creating innovative treatments for rare neurological diseases via a patient-centered drug development model. They maintain a pipeline of compounds targeting sleepwake disorders, neurobehavioral issues, and rare epilepsy through clinical trials and licensing partnerships. Headquartered in Plymouth Meeting, Pennsylvania, they address unmet medical needs for patients with conditions like narcolepsy and Fragile X syndrome.
Epygenix's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
Epygenix offers Pitolisant, ZYN002, EPX-100, and BP1.15205.